Replies to post #314789 on Amarin Corp Plc (AMRN)

[Examiner77]

Effect of Vascepa on COVID presented at NLA, 14 days after onset:
1) improved inflammatory markers
2) improved symptoms,
3) minor side effects even with high dose (8 g).
This is a pilot study and open label, so the evidence is still low, however it's a V. PROMISING RESULT.

NOW TO PREPARE-IT ????